No definition available.
Non-seminoma of testis, excluding all cancers (controls excluding all cancers)
C3_TESTIS_NONSEMINOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
225 |
4. Check minimum number of eventsNone |
225 |
5. Include endpointsNone |
225 |
6. Filter based on genotype QC (FinnGen only) |
225 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Non-seminoma of testis, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Non-seminoma of testis
- Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 225 | - | 225 |
| Unadjusted period prevalence (%) | 0.10 | - | 0.10 |
| Median age at first event (years) | 30.78 | - | 30.78 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 203
- Matched controls
- 2029
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
194.4
154
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
1348.5
192.0
158
5
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
796.1
143.3
125
*
130
Kela drug reimbursment
Malignant tumour
+∞
114.8
99
*
A03FA01
ATC
metoclopramide; systemic, rectal
29.3
67.6
95
59
JN4BD
NOMESCO Finland
Extensive body CT
41.2
66.7
84
34
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
65.2
59
*
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
57.0
52
*
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
50.1
46
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
46.7
43
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
45.6
42
*
L03AA02
ATC
filgrastim; parenteral
505.2
42.8
41
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
17.4
37.9
62
50
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
37.7
35
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
+∞
36.6
34
*
A04AA02
ATC
granisetron; systemic, transdermal
415.0
36.2
35
*
JN4AD
NOMESCO Finland
Body CT examination
61.8
35.0
40
8
H02AB02
ATC
dexamethasone; systemic
68.4
34.7
39
7
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
32.1
30
*
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
31.0
29
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
31.0
29
*
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
29.9
28
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.8
29.6
118
393
A04AA01
ATC
ondansetron; systemic, rectal
45.3
25.7
31
8
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
25.6
24
*
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
25.6
24
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
25.6
24
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
24.5
23
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
23.4
22
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
7.1
20.8
55
101
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
20.1
19
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
51.6
19.6
23
5
DFF00
NOMESCO Finland
Pure tone audiometry
9.7
18.3
38
47
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
18.0
17
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
16.9
16
*
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
16.9
16
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
16.9
16
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
16.6
15.8
25
17
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
15.8
15
*
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
15.8
15
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.1
15.6
73
247
JN3AD
NOMESCO Finland
Abdominal CT examination
8.7
15.2
33
44
B01AB05
ATC
enoxaparin; parenteral
4.7
14.8
56
153
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
14.8
14
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
161.1
14.7
15
*
N02BE01
ATC
paracetamol; systemic, rectal
3.9
13.8
171
1174
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
9.7
13.8
28
33
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
149.6
13.6
14
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.4
13.1
81
333
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
12.6
12
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
12.6
12
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
12.9
12.1
21
18
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
5.9
11.9
34
67
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
11.6
11
*
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
11.6
11
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
11.6
11
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.0
11.2
31
59
B01AB10
ATC
tinzaparin; parenteral
11.5
11.1
20
19
ZXE00
NOMESCO Finland
One hour or less
2.9
10.7
82
381
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
+∞
10.5
10
*
WW500
NOMESCO Finland
Blood transfusion
20.1
10.4
15
8
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.0
10.3
23
32
WX402
NOMESCO Finland
General anaesthesia
3.9
10.1
44
135
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
9.9
40
114
N02AA05
ATC
oxycodone; systemic
5.5
9.6
28
57
L03AA13
ATC
pegfilgrastim; parenteral
+∞
9.4
9
*
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
9.4
9
*
WZC30
NOMESCO Finland
Teaching
4.1
8.5
33
91
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
8.4
8
*
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
8.4
8
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
15.3
8.3
13
9
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
8.3
70
336
ZXD10
NOMESCO Finland
Scheduled procedure
2.6
8.2
70
339
Y05
ICPC
Scrotum/testis sympt/compl other
10.0
7.9
15
16
N05BA06
ATC
lorazepam; systemic, sublingual
6.6
7.8
19
31
ZX120
NOMESCO Finland
Intravenous
5.0
7.7
24
53
R50.9
ICD-10 Finland
Fever, unspecified
3.5
7.7
36
117
M04AA01
ATC
allopurinol; systemic
4.4
7.4
26
65
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
7.3
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
Y78
ICPC
Malign neopl male genital other
+∞
7.3
7
*
9071/3-C62.9
ICD-O-3
Yolk sac tumor, NOS, of testis, NOS
+∞
7.3
7
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
7.3
7
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
7.3
7
*
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
16.5
7.3
11
7
JN4CD
NOMESCO Finland
Very extensive body CT
20.9
7.2
10
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
7.1
25
63
WX320
NOMESCO Finland
Spinalanesthesy
3.0
6.9
40
152
N02AX02
ATC
tramadol; systemic, rectal
2.3
6.7
78
435
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
12.8
6.7
11
9
A02BC02
ATC
pantoprazole; systemic
2.1
6.5
107
697
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
6.4
33
116
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
D29.2
ICD-10 Finland
Benign neoplasm: Testis
+∞
6.3
6
*
E29.1
ICD-10 Finland
Testicular hypofunction
7.1
6.2
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023323) Follitropin [Units/volume] in Serum or Plasma
72
35
29.78
99.36
3.4
1.5
iu/l
18.3
8.4
2.14
55
27
(4035726)
72
39
26.68
94.87
1.1
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
80
5
246.32
82.35
12.1
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
86
86
15.57
81.51
3.2
1.6
u/l
8.7
4.2
3.73
70
79
(3021879) Hepatitis B virus core Ab [Presence] in Serum
83
210
5.68
32.93
1.4
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
107
380
4.46
27.15
1.9
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
94
304
4.59
26.98
1.6
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
94
311
4.47
26.05
1.7
1.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
34
43
9.14
25.86
1.4
3.1
%
177.3
174.5
0.04
34
43
(3015377) Calcium [Moles/volume] in Serum or Plasma
97
338
4.29
24.89
6.1
1.9
mmol/l
2.4
2.4
0.39
89
304
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
31
40
8.83
23.13
1.3
3.6
g/l
3.5
3.9
0.41
31
40
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
126
556
3.88
22.54
9.9
6.7
mmol/l
1.2
1.2
0.25
102
487
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
27
31
9.76
22.00
2.6
6.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
27
31
9.76
22.00
1.3
3.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
115
488
3.77
21.61
4.7
3.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
89
322
3.92
21.13
2.8
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
74
249
3.94
19.29
2.4
2.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
159
875
3.79
19.22
14.2
8.5
e9/l
3.4
4.1
5.43
145
768
(3003694) ABO and Rh group [Type] in Blood
94
373
3.61
19.13
1.4
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
87
330
3.67
18.95
7.0
3.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
91
364
3.52
18.13
3.3
2.6
e6/l
17.8
211.3
0.55
70
275
(3024561) Albumin [Mass/volume] in Serum or Plasma
114
535
3.29
17.34
11.4
4.1
g/l
36.9
37.4
0.38
107
505
(3030467) Casts [#/volume] in Urine by Automated count
84
329
3.48
17.17
3.0
2.6
e6/l
0.6
0.3
0.42
64
238
(3018095) Leukocytes [#/volume] in Urine
97
420
3.30
16.77
3.9
2.9
e6/l
51.8
96.7
0.21
72
286
(36304419) Bacteria [Presence] in Urine
83
328
3.43
16.65
2.9
2.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
99
438
3.25
16.45
3.3
2.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
106
493
3.17
16.10
5.2
6.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
25
8.68
15.13
3.9
2.3
u/ml
0.3
0.3
0.13
12
14
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
24
38
6.95
14.88
2.6
1.7
ug/l
4.9
2.3
1.09
18
29
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
57
191
3.66
14.58
2.8
2.4
e6/l
0.6
0.8
0.17
33
92
(46235355) HIV 1 and 2 tests - Meaningful Use set
100
472
3.01
14.48
2.0
2.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
58
199
3.58
14.29
2.8
2.4
e6/l
1.0
0.7
0.23
34
99
(3037467) Urinalysis macro (dipstick) panel - Urine
147
872
2.98
13.71
3.9
2.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
76
319
3.09
13.39
7.5
2.8
ph
7.4
7.4
0.84
26
56
(3002030) Lymphocytes/100 leukocytes in Blood
134
763
2.87
13.38
5.9
6.5
%
27.8
29.1
0.66
129
736
(3002256) Pathology report gross observation
39
108
4.16
12.98
1.2
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
93
453
2.79
12.31
8.9
7.3
inr
1.1
1.2
0.36
29
142
(3021589) Normoblasts [#/volume] in Blood
121
692
2.62
11.39
9.8
7.7
e9/l
0.0
0.0
0.00
96
562
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
70
309
2.84
10.99
1.6
2.0
mg/l
1.7
0.8
1.83
50
216
(3026782) Osmolality of Urine
58
235
2.98
10.62
2.3
2.2
mosm/kgh2o
605.0
579.2
0.29
51
196
(3019198) Lymphocytes [#/volume] in Blood
131
797
2.54
10.57
5.8
7.0
e9/l
1.7
1.9
1.97
116
715
(3001604) Monocytes [#/volume] in Blood
127
764
2.52
10.47
5.4
6.8
e9/l
0.6
0.6
0.11
108
674
(3006315) Basophils [#/volume] in Blood
127
766
2.51
10.38
5.4
6.8
e9/l
0.0
0.0
0.60
108
680
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
48
177
3.18
10.32
2.6
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
205
1582
4.33
10.28
20.8
7.8
ml/min/173m2
97.1
95.8
0.33
184
1274
(3000850) Epithelial cells [#/volume] in Urine
57
234
2.92
10.16
2.7
2.2
e6/l
3.5
2.2
0.43
50
204
(3013115) Eosinophils [#/volume] in Blood
128
784
2.47
9.99
5.8
7.4
e9/l
0.2
0.2
2.31
111
702
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
28
74
4.18
9.84
5.4
2.3
mmol/l
1.2
1.2
0.25
28
67
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
23
6.42
8.28
2.1
4.3
e9/l
3.8
3.8
0.01
14
23
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
24
6.15
7.95
2.2
4.4
%
59.9
54.2
1.06
14
24
(40758558) Short blood count panel - Blood
70
360
2.37
7.70
11.4
5.8
—
—
—
0
0
(3019225) pH of Specimen
29
96
3.32
7.35
5.3
3.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
26
5.68
7.35
1.6
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
13
8.00
7.17
1.0
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
126
3.00
7.15
2.7
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
206
1698
3.52
7.13
23.0
9.1
mg/l
22.0
23.4
0.27
176
1262
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
20
6.28
6.98
1.1
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
28
5.27
6.80
1.6
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
31
114
2.99
6.60
4.0
2.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
33
129
2.83
6.30
2.7
1.6
—
—
—
0
0
(3013512) EKG study
61
321
2.24
6.21
3.3
3.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
78
3.17
5.60
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
215
1881
4.22
5.48
15.2
7.4
u/l
34.2
35.5
0.45
215
1833
(3000991) Gas panel - Venous blood
29
123
2.56
4.72
7.6
8.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
93
621
1.85
4.69
2.9
2.5
estimate
0.0
0.0
0.00
24
107
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
5
14.38
4.60
1.0
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
5
14.38
4.60
1.0
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
5
14.38
4.60
1.0
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
5
14.38
4.60
1.0
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
22
82
2.87
4.57
2.7
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
34
158
2.36
4.56
3.1
2.1
%
25.3
26.1
0.12
29
142
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
39
3.76
4.56
2.1
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
60
3.17
4.51
10.3
18.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
12
7.76
4.39
1.0
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
92
625
1.80
4.30
4.4
3.5
estimate
0.0
0.0
0.00
25
114
(40761511) CBC panel - Blood by Automated count
207
1824
2.69
4.17
23.2
7.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
64
2.97
4.06
1.7
1.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
7
10.27
4.04
2.6
1.1
u/l
186.1
181.7
—
7
7
(3019832) Treponema pallidum Ab [Presence] in Serum
37
190
2.13
3.92
1.7
2.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
30
144
2.25
3.74
2.8
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
12
6.86
3.70
1.0
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
12
6.86
3.70
1.0
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
12
6.86
3.70
1.0
1.3
—
—
—
0
0
(3000492) Spirometry study
41
224
2.02
3.68
2.2
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
23
100
2.45
3.57
3.1
2.8
—
—
—
0
0
(3015736) pH of Urine
74
497
1.73
3.47
3.0
2.7
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
20
83
2.55
3.41
5.4
12.4
%
95.7
93.5
1.70
20
83
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
7
10
7.18
3.39
12.0
10.0
mg/l
8.7
10.2
—
7
10
(4038314)
7
10
7.18
3.39
1.1
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
89
633
1.67
3.36
3.0
2.5
estimate
0.0
0.0
0.00
21
99
(3042936) Bacteria identified in Isolate by Culture
34
186
1.98
3.04
2.0
2.1
—
—
—
0
0
(3044889) 12 lead EKG panel
127
1005
1.61
3.03
3.3
2.9
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
10
30
3.44
2.94
1.6
1.9
%
68.3
67.3
—
10
30
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
19
83
2.41
2.93
5.6
12.3
%
0.6
0.7
1.11
19
83
(3011648) Oxygen content in Venous blood
7
13
5.52
2.89
1.6
2.5
%
11.9
12.9
—
7
13
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
19
84
2.38
2.86
5.3
12.2
%
1.4
1.8
0.58
19
84
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
36
3.16
2.85
2.3
1.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
23
111
2.19
2.84
8.6
14.5
g/l
119.3
133.1
1.63
23
106
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
18
4.57
2.82
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
18
4.57
2.82
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
18
4.57
2.82
1.1
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
217
2040
2.79
2.72
34.1
13.0
e9/l
6.4
6.5
0.28
211
1996
(3026361) Erythrocytes [#/volume] in Blood
217
2040
2.79
2.72
34.1
12.9
e12/l
4.7
4.9
4.65
210
1993
(3035941) MCH [Entitic mass]
217
2039
2.81
2.72
33.9
12.9
pg
30.2
30.2
0.16
217
2014
(3024731) MCV [Entitic volume]
217
2039
2.81
2.72
34.0
12.9
fl
89.4
89.3
0.26
217
2014
(3007461) Platelets [#/volume] in Blood
217
2037
2.84
2.71
34.2
12.9
e9/l
237.8
241.7
0.51
211
1993
(4268621)
8
20
4.11
2.59
2.5
2.8
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
217
2041
2.78
2.57
34.3
13.0
g/l
141.3
147.8
6.71
217
2014
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
70
500
1.58
2.48
2.8
2.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
42
264
1.73
2.44
2.3
2.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
40
2.84
2.41
1.4
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
89
677
1.52
2.36
3.4
2.8
ug/l
1.2
1.4
0.74
77
625
(3022313) Gas panel - Capillary blood
15
66
2.36
2.30
3.5
3.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
18
3.98
2.27
2.1
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
18
3.98
2.27
2.1
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
54
373
1.59
2.18
3.1
2.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
102
2.05
2.18
1.3
1.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
8
25
3.28
2.11
5.1
2.9
mmol/l
1.3
1.4
—
8
25
(4034850)
0
55
0.00
2.10
0.0
5.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
31
2.98
2.09
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
20
3.58
2.07
1.4
1.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
15
70
2.22
2.03
2.4
4.0
e9/l
41.5
73.7
—
9
46
(3038515) Glucose [Moles/volume] in Venous blood
7
21
3.41
1.98
5.4
3.2
mmol/l
6.8
7.1
—
7
21
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
21
3.41
1.98
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
11
4.62
1.95
1.0
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
39
2.64
1.95
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
22
3.25
1.89
2.1
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
157
1739
0.68
1.85
4.2
3.8
mmol/l
2.9
2.9
0.19
149
1647
(3024928) Oxygen saturation in Venous blood
9
35
2.64
1.82
1.4
2.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
16
81
2.05
1.79
6.0
3.7
mmol/l
24.3
23.7
0.36
16
75
(3000330) Specific gravity of Urine by Test strip
10
41
2.51
1.78
2.8
3.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
28
173
1.71
1.74
1.5
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
22
127
1.81
1.71
3.6
4.7
%
4.0
0.8
1.70
12
34
(40768443) Skin Pathology biopsy report
10
42
2.45
1.70
1.0
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
10
42
2.45
1.70
11.3
14.7
%
1.4
1.5
—
10
37
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
16
83
2.00
1.69
3.4
3.4
mmol/l
-0.7
1.9
1.65
11
52
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
157
1727
0.70
1.62
4.1
3.6
mmol/l
4.6
4.7
0.08
152
1639
(44806118)
5
14
3.63
1.62
2.4
1.9
—
—
—
0
0
(44790048)
5
14
3.63
1.62
2.4
1.9
—
—
—
0
0
(44790047)
5
14
3.63
1.62
2.4
1.9
—
—
—
0
0
(44790049)
5
14
3.63
1.62
2.4
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
43
302
1.52
1.61
3.1
2.7
estimate
0.1
0.0
0.41
24
107
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
43
0.00
1.54
0.0
1.1
—
8.8
—
0
32
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
15
3.38
1.53
2.4
3.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
27
2.64
1.52
2.1
3.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
157
1719
0.71
1.48
4.0
3.5
mmol/l
1.2
1.3
4.44
151
1632
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
38
2.42
1.47
1.2
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
20
118
1.76
1.47
2.4
4.4
%
2.7
0.3
—
10
24
(3000570) Elastase.pancreatic [Mass/mass] in Stool
7
28
2.55
1.46
1.6
1.3
ug/g
316.9
329.4
—
7
19
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
16
3.17
1.44
1.2
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
9
40
2.30
1.42
1.2
1.2
—
94.0
—
0
8
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
62
480
1.40
1.41
3.7
2.8
ng/l
41.5
65.6
0.32
43
259
(42529406) Shigella sp [Presence] in Stool by Culture
11
53
2.13
1.41
1.6
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
29
2.46
1.40
1.7
1.1
—
—
—
0
0
(4306422)
7
29
2.46
1.40
1.1
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
29
2.46
1.40
1.7
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
17
2.98
1.36
1.2
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
123
1068
1.33
1.33
3.9
3.4
mm/h
10.8
7.7
1.32
118
1001
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
24
2.54
1.31
1.3
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
49
2.09
1.24
1.0
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
37
268
1.46
1.21
4.0
3.2
ng/l
657.1
1244.5
0.44
28
184
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
35
251
1.47
1.20
2.3
2.8
ng/l
609.2
1580.4
0.79
28
189
(3013290) Carbon dioxide [Partial pressure] in Blood
6
26
2.34
1.19
5.8
2.1
kpa
5.3
4.9
—
6
26
(3012501) Base excess in Blood by calculation
6
26
2.34
1.19
5.8
2.1
mmol/l
3.1
2.4
—
6
7
(3027315) Oxygen [Partial pressure] in Blood
6
26
2.34
1.19
5.8
2.1
kpa
9.0
8.6
—
6
26
(21494755) Public health laboratory ask at order entry panel
25
360
0.66
1.17
1.3
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
33
0.00
1.17
0.0
1.0
—
1.4
—
0
8
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
152
1653
0.75
1.17
3.7
3.3
mmol/l
1.5
1.4
1.32
145
1573
(1761868) Lipid panel - Serum or Plasma
63
771
0.75
1.16
2.8
2.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
39
2.09
1.16
10.8
2.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
64
516
1.34
1.12
3.2
2.7
%
24.5
24.1
0.03
18
146
(3007566) Smooth muscle Ab [Titer] in Serum
12
67
1.84
1.07
1.3
1.2
—
58.0
—
0
10
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
11
60
1.88
1.04
8.5
3.2
%
60.8
57.1
0.17
11
60
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
22
2.30
1.04
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
53
1.93
1.03
1.3
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
53
1.93
1.03
1.3
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
19
124
1.58
1.00
3.8
4.7
%
0.9
0.1
1.76
11
31
(40760892) CBC W Ordered Manual Differential panel - Blood
48
377
1.35
1.00
4.0
5.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
63
1.78
0.92
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
29
2.10
0.90
2.8
2.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
55
450
1.29
0.87
2.2
1.6
pmol/l
92.4
95.5
0.18
36
236
(4010399)
14
88
1.63
0.86
1.0
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
57
1.79
0.85
1.1
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
11
67
1.67
0.76
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
133
0.59
0.76
1.0
1.8
—
—
—
0
0
(3020891) Body temperature
9
54
1.69
0.75
2.9
6.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
100
1.54
0.75
1.3
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
25
2.02
0.73
1.0
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
57
1.60
0.72
1.1
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
17
118
1.48
0.71
4.1
4.8
%
0.0
0.0
—
10
26
(3009542) Hematocrit [Volume Fraction] of Blood
187
1782
1.29
0.71
26.1
9.3
%
40.5
43.2
3.21
162
1510
(3022145) Colonoscopy Study observation
20
144
1.43
0.71
1.8
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
23
171
1.38
0.69
1.2
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
27
1.87
0.69
1.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
44
1.61
0.65
2.9
2.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
46
382
1.26
0.65
1.7
2.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
117
1069
1.20
0.65
3.0
2.7
pmol/l
15.1
14.9
0.34
104
990
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
144
1534
0.83
0.64
3.6
3.3
mmol/l
6.0
5.9
0.24
136
1438
(3037522) Nuclear Ab [Titer] in Serum
28
218
1.32
0.64
1.2
1.3
titre
262.9
286.5
—
7
31
(3024980) IgG subclass 4 [Mass/volume] in Serum
5
30
1.68
0.62
1.4
1.3
g/l
0.4
0.9
—
5
22
(3012516) Albumin [Mass/volume] in Urine
41
340
1.25
0.59
3.8
4.0
mg/l
31.3
92.8
1.85
31
243
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
46
388
1.23
0.57
2.8
2.0
ug/l
0.6
0.7
0.35
28
186
(3001019) Free T4 and TSH panel - Serum or Plasma
5
90
0.55
0.57
1.4
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
137
1454
0.85
0.53
5.0
4.4
mmol/mol
39.4
38.9
0.19
131
1395
(3027008) Opiates [Presence] in Urine
20
257
0.76
0.52
2.3
2.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
20
257
0.76
0.52
2.8
2.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
11
75
1.49
0.51
3.6
2.8
ng/l
57.3
180.7
1.30
11
65
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
67
1.52
0.50
1.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
255
0.76
0.50
2.3
2.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
20
252
0.77
0.46
2.3
2.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
49
1.44
0.46
1.3
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
49
1.44
0.46
1.7
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
44
380
1.20
0.45
2.0
1.6
mmol/l
1.7
1.7
0.01
38
334
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
195
0.75
0.43
2.7
3.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
92
0.64
0.43
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
19
238
0.78
0.42
2.4
2.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
32
1.57
0.42
1.0
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
2.6
—
0
5
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
35
1.44
0.39
1.4
3.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
72
1.41
0.37
1.5
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
9
71
1.28
0.36
12.8
15.9
mmol/l
23.6
24.1
—
9
66
(3020682) Albumin/Creatinine [Ratio] in Urine
41
364
1.15
0.31
4.3
4.9
mg/mmol
8.8
15.0
0.42
32
261
(1002224) Polysomnography panel
10
130
0.76
0.30
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
23
269
0.84
0.29
1.6
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
57
1.24
0.29
1.1
2.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
39
348
1.15
0.28
1.7
2.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
162
1669
0.90
0.28
30.9
11.1
g/l
337.0
337.7
0.47
162
1664
(3011288) Drugs identified in Urine by Screen method
14
171
0.81
0.27
3.6
4.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
37
412
0.88
0.26
1.2
1.2
u/ml
0.5
1.0
—
9
120
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
105
1.25
0.25
1.2
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
10
79
1.28
0.22
1.2
2.0
—
10.5
—
0
6
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4146454)
0
11
0.00
0.21
0.0
3.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
11
0.00
0.21
0.0
1.5
—
33.6
—
0
11
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.4
—
0
5
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
4.8
—
420.8
—
0
12
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
14
117
1.21
0.21
1.3
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
10
80
1.26
0.21
11.2
11.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
141
1368
1.08
0.20
3.6
3.3
mu/l
1.7
2.7
0.58
130
1280
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
23
203
1.15
0.20
1.4
1.7
pmol/l
406.1
429.7
0.26
18
181
(3025941) Bacteria identified in Stool by Culture
11
91
1.22
0.18
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
61
1.15
0.17
2.1
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
148
1515
0.93
0.16
3.2
3.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
39
364
1.09
0.14
1.4
1.3
g/l
2.5
2.4
0.09
28
238
(40761535) Cells panel - Urine sediment
8
95
0.84
0.14
2.1
2.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
100
0.79
0.14
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
43
457
0.93
0.13
1.6
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
105
0.85
0.13
3.1
4.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
19
171
1.12
0.13
1.7
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
51
485
1.07
0.12
3.5
3.9
mmol/l
9.9
9.6
0.14
43
436
(3020961) Endomysium IgA Ab [Titer] in Serum
11
95
1.17
0.12
1.2
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
135
0.88
0.10
9.8
6.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
48
1.04
0.09
1.0
1.1
—
1.1
—
0
7
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
64
1.10
0.08
1.0
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
120
0.91
0.05
3.1
3.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
103
1.07
0.02
2.6
2.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
33
338
0.97
0.02
1.2
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
187
0.96
0.01
1.2
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
14
142
0.98
0.00
1.1
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
37.7
—
0
5
(3005322) IgE [Units/volume] in Serum or Plasma
9
99
0.91
0.00
1.1
1.3
u/ml
197.0
281.2
—
9
91
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
107.2
—
0
6
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
2.0
—
0
8
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
16.7
—
0
6
(3006245) CD3-CD19+ cells/100 cells in Blood
0
7
0.00
0.00
0.0
5.3
—
10.4
—
0
7
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
59
1.02
0.00
1.2
1.6
—
—
—
0
0
(44813793)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
270.0
—
0
9
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
6.2
—
24.1
—
0
6
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
0
7
0.00
0.00
0.0
3.3
—
25.6
—
0
7
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
3.6
—
105.7
—
0
7
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
7
0.00
0.00
0.0
1.4
—
391.0
—
0
7
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
11.0
—
0
7
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
137.8
—
0
6
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
49
1.02
0.00
3.6
1.9
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_TESTIS_NONSEMINOMA_EXALLC – Non-seminoma of testis, excluding all cancers (controls excluding all cancers)
GWS hits: 2
This endpoint is excluded (different definition than used in FinnGen).